We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Stealth BioTherapeutics Corp. ADS in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $277K → $0 (-$277K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 12

Holders
–
Holders Change
-12
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$134K
2
BBHC
Brown Brothers Harriman & Co
New York
-$54K
3
Renaissance Technologies
Renaissance Technologies
New York
-$30K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$15K
5
BFM
Boothbay Fund Management
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
– -$134K -435,516 Closed
BBHC
2
Brown Brothers Harriman & Co
New York
– -$54K -174,999 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
– -$30K -96,944 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
– -$15K -48,791 Closed
BFM
5
Boothbay Fund Management
New York
– -$14K -43,790 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– -$10K -30,991 Closed
Envestnet Asset Management
7
Envestnet Asset Management
Illinois
– -$7K -23,248 Closed
CAPTRUST Financial Advisors
8
CAPTRUST Financial Advisors
North Carolina
– -$5K -15,000 Closed
Two Sigma Advisers
9
Two Sigma Advisers
New York
– -$4K -13,700 Closed
Osaic Holdings
10
Osaic Holdings
Arizona
– -$3K -10,124 Closed
AA
11
AlphaMark Advisors
Kentucky
– -$1K -2,306 Closed

MITO Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q4 2022, worth a combined $0 — down 100% from $277K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MITO and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ikarian Capital, exiting entirely with an estimated $134K sold.

  • 0 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q4 2022, down from 12 in Q3 2022.
  • Funds reported $0 of Stealth BioTherapeutics Corp. ADS stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q4 2022 and 12 closed out, a net change of -12 holders.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q4 2022 was Ikarian Capital, an estimated $134K sold.

Based on aggregated 13F filings for Q4 2022.